Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment

Clinical trial NCT02535299 · UNKNOWN

Trial details

NCT number: NCT02535299
Sponsor: Third Military Medical University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

GLP-1；Metformin；Telomere-telomerase System；Par-4

Start date: 2016-06-01
Primary completion: 2018-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.